Local control of metastatic sites with radiation therapy in metastatic Ewing sarcoma and rhabdomyosarcoma

Pediatric Blood and Cancer

Volumn 57, Issue 1, 2011, Pages 169-171

  Liu, Arthur K ^a   Stinauer, Michelle ^a   Albano, Edythe ^b   Greffe, Brian ^b   Tello, Tiffany ^a   Maloney, Kelly ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Pediatrics   (United States)

Author keywords

Ewing sarcoma; Radiation therapy; Rhabdomyosarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; EWING SARCOMA; FEMALE; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; RADIATION SICKNESS; RHABDOMYOSARCOMA; SCHOOL CHILD; TREATMENT FAILURE;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; SARCOMA, EWING'S; SURVIVAL RATE;

EID: 79955736173     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23063     Document Type: Article

References (17)

1. Ries L, Eisner M, Kosary C, et al. editors. SEER Cancer Statistics Review 1975-2002. Bethesda, MD: National Cancer Institute; 2005.
2. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001; 19: 3091-3102.
3. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694-701.
4. Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-A report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21: 78-84.
5. Miser JS, Krailo MD, Tarbell NJ, et al. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: Evaluation of combination ifosfamide and etoposide-A Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol 2004; 22: 2873-2876.
6. Miser JS, Goldsby RE, Chen Z, et al. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy-A report from the Children's Oncology Group. Pediatr Blood Cancer 2007; 49: 894-900.
7. Oberlin O, Rey A, Lyden E, et al. Prognostic factors in metastatic rhabdomyosarcomas: Results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 2008; 26: 2384-2389.
8. Haeusler J, Ranft A, Boelling T, et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer 2010; 116: 443-450.
9. La TH, Meyers PA, Wexler LH, et al. Radiation therapy for Ewing's sarcoma: Results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys 2006; 64: 544-550.
10. Yock TI, Krailo M, Fryer CJ, et al. Local control in pelvic Ewing sarcoma: Analysis from INT-0091-A report from the Children's Oncology Group. J Clin Oncol 2006; 24: 3838-3843.
11. Paulino AC, Nguyen TX, Mai WY. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma. Pediatr Blood Cancer 2007; 48: 423-429.
12. Paulino AC, Nguyen TX, Mai WY, et al. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma. Pediatr Blood Cancer 2007; 49: 145-148.
13. Rodriguez-Galindo C, Navid F, Liu T, et al. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol 2008; 19: 814-820.
14. Granowetter L, Womer R, Devidas M, et al. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study. J Clin Oncol 2009; 27: 2536-2541.
15. Wharam MD, Meza J, Anderson J, et al. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: A report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 2004; 22: 1902-1908.
16. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114.
17. Carli M, Colombatti R, Oberlin O, et al. European intergroup studies (MMT 4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol 2004; 22: 4787-4794.